Mycology laboratory diagnostic capacity for invasive fungal diseases in public hospitals in Vietnam.

IF 2.7 3区医学 Q3 INFECTIOUS DISEASES

Medical mycology Pub Date : 2024-08-02 DOI:10.1093/mmy/myae082

Vu Ngoc Hieu, Nguyen Le Hiep, Le Minh Hang, Bianca A Lau-Goodchild, Nguyen Van Duong, Nguyen Thuy Linh, Justin Beardsley, Vu Quoc Dat

引用次数: 0

Abstract

This was a cross-sectional study on the availability of laboratory infrastructure and capacity for the diagnosis of invasive fungal diseases in 24 public hospitals in Vietnam in 2023. Among the hospitals surveyed, 66.7% (14/21) had specialized personnel assigned for mycology testing, and 95.8% (23/24) had a separate microbiology laboratory space. Microscopy and culture methods are available in nearly all laboratories for isolate identification. Antifungal susceptibility testing is only performed for yeasts in 16/24 (66.7%) laboratories. Non-culture methods are hardly used in laboratories. Strengthening local laboratory capacities is essential to meeting health needs in these endemic regions.

查看原文本刊更多论文

越南公立医院真菌学实验室对侵袭性真菌疾病的诊断能力。

这是一项横断面研究，研究对象是2023年越南24家公立医院用于诊断侵袭性真菌疾病的实验室基础设施和能力。在接受调查的医院中，66.7%（14/21）的医院有专门人员负责真菌学检测，95.8%（23/24）的医院有独立的微生物实验室空间。几乎所有实验室都有显微镜和培养方法用于分离鉴定。16/24（66.7%）个实验室只对酵母菌进行抗真菌药敏试验。实验室几乎不使用非培养方法。加强地方实验室能力对于满足这些地方病流行地区的卫生需求至关重要。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Medical mycology 医学-兽医学

CiteScore

5.70

自引率

3.40%

发文量

632

审稿时长

12 months

期刊介绍： Medical Mycology is a peer-reviewed international journal that focuses on original and innovative basic and applied studies, as well as learned reviews on all aspects of medical, veterinary and environmental mycology as related to disease. The objective is to present the highest quality scientific reports from throughout the world on divergent topics. These topics include the phylogeny of fungal pathogens, epidemiology and public health mycology themes, new approaches in the diagnosis and treatment of mycoses including clinical trials and guidelines, pharmacology and antifungal susceptibilities, changes in taxonomy, description of new or unusual fungi associated with human or animal disease, immunology of fungal infections, vaccinology for prevention of fungal infections, pathogenesis and virulence, and the molecular biology of pathogenic fungi in vitro and in vivo, including genomics, transcriptomics, metabolomics, and proteomics. Case reports are no longer accepted. In addition, studies of natural products showing inhibitory activity against pathogenic fungi are not accepted without chemical characterization and identification of the compounds responsible for the inhibitory activity.